Some thoughts and observations: Unless I missed something, all this release showed was that Arcam was presenting its wares at an expo. I could not discern any news at all.
Generic GE news and generic 3d sector news doesn't improve my insight or understanding of how Arcam is progressing. My concerns, which the company does not placate, are not addressed in repeated PRs or news releases from GE and other sector leaders. As the right of the screen suggests this is the arcam board and we need info about the arcam stock and company.
For example, knowing that GE is spending a lot on 3d is well known and may be pertinent to GE of which I also own stock. but does not help on the arcam issue. How much money is ge giving to arcam. Based on what I DISCERN FROM POSTINGS HERE, GE IS GIVING A Lot more to concept that arcam. In its sample plants, how many arcam printers are in place vs concept and other machines. will the new GE model printer use laser vs arcam technology. Will it have any Arcam technology in it?? All the posters here assumed that this prnter and all the money GE is spending impacts Arcam. Not necessarily so. Besides the Avio blades is GE, any other company, contemplating ebM parts or so far are the blades it. When will the 9x and EBM blades reach the mass production level, thus needing a lot of printers. So far we are receiving no information and just because GE is spending money on 3d does not mean Arcam is advantaged.
Moreover, lets face it the stock, both ADS and original are performing zombie lack with pathetic volume (papa arcam sometimes having even less volume than baby and baby sometimes not selling at all.) God help anyone trying to buy or sell any appreciable amount without destroying the pricing. And amongst the few divergent postings, Photogenesis seems to be the topic of choice on this board and my concern is whether the manufacturing of powder, using the same or better technology than APC which got its machines and technology from Photogenesis will hurt apc SALES. APC for the last year has been the one strong spot for arcam, with arcam sales lackluster since 2015 and Di Santo a trouble spot. We shall see but would be nice to get some real ARCAM news and see that the EBM technology is being adopted by others.
